Gonadotropin-releasing hormone antagonist: new tools vs. old habits

被引:19
作者
Bouchard, P
Fauser, BCJM
机构
[1] Hop St Antoine, Serv Endocrinol, F-75012 Paris, France
[2] Erasmus Univ, Med Ctr, Dept Obstet & Gynecol, Rotterdam, Netherlands
关键词
D O I
10.1016/S0015-0282(99)00446-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:18 / 20
页数:3
相关论文
共 12 条
[1]   Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation [J].
Albano, C ;
Smitz, J ;
Camus, M ;
RiethmullerWinzen, H ;
VanSteirteghem, A ;
Devroey, P .
FERTILITY AND STERILITY, 1997, 67 (05) :917-922
[2]  
[Anonymous], 1998, Hum Reprod, V13, P3023
[3]   Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues [J].
Barbieri, RL ;
Hornstein, MD .
ENDOCRINE REVIEWS, 1999, 20 (03) :249-252
[4]  
de Jong D, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P195
[5]   SUPPRESSION OF THE ENDOGENOUS LUTEINIZING-HORMONE SURGE BY THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX DURING OVARIAN STIMULATION [J].
DIEDRICH, K ;
DIEDRICH, C ;
SANTOS, E ;
ZOLL, C ;
ALHASANI, S ;
REISSMANN, T ;
KREBS, D ;
KLINGMULLER, D .
HUMAN REPRODUCTION, 1994, 9 (05) :788-791
[6]   EFFECT OF ADMINISTRATION OF A GONADOTROPIN-RELEASING-HORMONE (GNRH) ANTAGONIST (NAL-GLU) DURING THE PERIOVULATORY PERIOD - THE LUTEINIZING-HORMONE SURGE REQUIRES SECRETION OF GNRH [J].
DUBOURDIEU, S ;
CHARBONNEL, B ;
DACREMONT, MF ;
CARREAU, S ;
SPITZ, IM ;
BOUCHARD, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) :343-347
[7]   Manipulation of human ovarian function: Physiological concepts and clinical consequences [J].
Fauser, BCJM ;
VanHeusden, AM .
ENDOCRINE REVIEWS, 1997, 18 (01) :71-106
[8]   Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks [J].
Fauser, BCJM ;
Devroey, P ;
Yen, SSC ;
Gosden, R ;
Crowley, WF ;
Baird, DT ;
Bouchard, P .
HUMAN REPRODUCTION, 1999, 14 (11) :2681-2686
[9]  
FRYDMAN R, 1991, FERTIL STERIL, V56, P923
[10]   High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles [J].
Kol, S ;
Lightman, A ;
Hillensjo, T ;
Devroey, P ;
Fauser, B ;
Tarlatzis, B ;
Mannaerts, B ;
Itskovitz-Eldor, J .
HUMAN REPRODUCTION, 1999, 14 (09) :2242-2244